| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Growth Retardation | 51 | 2019 | 54 | 13.240 |
Why?
|
| Epigenesis, Genetic | 29 | 2022 | 84 | 8.840 |
Why?
|
| Hippocampus | 15 | 2022 | 29 | 5.760 |
Why?
|
| Animals | 94 | 2022 | 896 | 5.490 |
Why?
|
| Placental Insufficiency | 18 | 2012 | 19 | 4.940 |
Why?
|
| Prenatal Exposure Delayed Effects | 15 | 2022 | 20 | 4.900 |
Why?
|
| Pregnancy | 67 | 2022 | 252 | 4.590 |
Why?
|
| Rats | 60 | 2015 | 208 | 3.950 |
Why?
|
| Animals, Newborn | 30 | 2021 | 66 | 3.260 |
Why?
|
| RNA, Messenger | 41 | 2022 | 180 | 3.190 |
Why?
|
| Female | 78 | 2022 | 3367 | 3.110 |
Why?
|
| Gene Expression Regulation, Developmental | 22 | 2018 | 76 | 2.980 |
Why?
|
| Rats, Sprague-Dawley | 42 | 2016 | 97 | 2.900 |
Why?
|
| DNA Methylation | 21 | 2022 | 101 | 2.760 |
Why?
|
| Liver | 19 | 2021 | 160 | 2.560 |
Why?
|
| Male | 51 | 2022 | 3284 | 2.470 |
Why?
|
| Histones | 15 | 2021 | 33 | 2.470 |
Why?
|
| Brain | 7 | 2018 | 92 | 2.280 |
Why?
|
| Brain Injuries | 4 | 2014 | 9 | 1.870 |
Why?
|
| Diet, High-Fat | 8 | 2021 | 14 | 1.740 |
Why?
|
| Receptors, Glucocorticoid | 9 | 2020 | 12 | 1.710 |
Why?
|
| Insulin-Like Growth Factor I | 9 | 2015 | 30 | 1.620 |
Why?
|
| Chromatin | 9 | 2015 | 25 | 1.590 |
Why?
|
| Placental Circulation | 6 | 2009 | 6 | 1.580 |
Why?
|
| Lung | 7 | 2019 | 92 | 1.550 |
Why?
|
| Obesity | 9 | 2017 | 116 | 1.530 |
Why?
|
| PPAR gamma | 6 | 2015 | 7 | 1.460 |
Why?
|
| Transcription Factors | 6 | 2015 | 92 | 1.420 |
Why?
|
| Disease Models, Animal | 15 | 2019 | 80 | 1.380 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 21 | 2012 | 89 | 1.370 |
Why?
|
| Intra-Abdominal Fat | 3 | 2014 | 5 | 1.370 |
Why?
|
| MicroRNAs | 5 | 2021 | 28 | 1.320 |
Why?
|
| Fetus | 7 | 2015 | 24 | 1.220 |
Why?
|
| Mice | 16 | 2022 | 453 | 1.190 |
Why?
|
| Cholesterol | 2 | 2016 | 16 | 1.170 |
Why?
|
| Apoptosis | 8 | 2009 | 66 | 1.120 |
Why?
|
| Corticosterone | 8 | 2018 | 8 | 1.080 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2010 | 52 | 1.070 |
Why?
|
| Kidney | 4 | 2010 | 90 | 1.050 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 58 | 1.010 |
Why?
|
| Gene-Environment Interaction | 4 | 2015 | 11 | 0.960 |
Why?
|
| Erythropoietin | 2 | 2014 | 19 | 0.950 |
Why?
|
| Fetal Development | 7 | 2020 | 12 | 0.930 |
Why?
|
| Dual-Specificity Phosphatases | 4 | 2021 | 4 | 0.920 |
Why?
|
| Muscle, Skeletal | 5 | 2015 | 17 | 0.910 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 22 | 0.880 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 15 | 0.870 |
Why?
|
| Uterus | 5 | 2017 | 9 | 0.870 |
Why?
|
| Monosaccharide Transport Proteins | 5 | 2002 | 5 | 0.860 |
Why?
|
| Blotting, Western | 14 | 2014 | 49 | 0.840 |
Why?
|
| Diet, Western | 5 | 2021 | 5 | 0.830 |
Why?
|
| Humans | 25 | 2022 | 6128 | 0.830 |
Why?
|
| Microglia | 2 | 2018 | 3 | 0.820 |
Why?
|
| Adipocytes | 3 | 2017 | 7 | 0.800 |
Why?
|
| Insulin Resistance | 2 | 2014 | 15 | 0.790 |
Why?
|
| Pulmonary Alveoli | 4 | 2013 | 12 | 0.770 |
Why?
|
| Hypertension | 3 | 2010 | 56 | 0.770 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 130 | 0.760 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 6 | 2016 | 6 | 0.750 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 8 | 0.750 |
Why?
|
| Maternal Exposure | 5 | 2020 | 8 | 0.740 |
Why?
|
| Stress, Physiological | 3 | 2019 | 10 | 0.740 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2018 | 2 | 0.730 |
Why?
|
| Anxiety | 1 | 2018 | 40 | 0.710 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2021 | 2 | 0.690 |
Why?
|
| Retinopathy of Prematurity | 2 | 2017 | 6 | 0.670 |
Why?
|
| Touch | 3 | 2013 | 4 | 0.660 |
Why?
|
| Caspases | 3 | 2014 | 5 | 0.650 |
Why?
|
| DNA Primers | 10 | 2011 | 41 | 0.640 |
Why?
|
| Lung Diseases | 3 | 2014 | 41 | 0.640 |
Why?
|
| Environment | 1 | 2016 | 7 | 0.640 |
Why?
|
| Brain Chemistry | 4 | 2014 | 8 | 0.630 |
Why?
|
| Receptors, LDL | 1 | 2016 | 7 | 0.630 |
Why?
|
| Immunohistochemistry | 9 | 2013 | 71 | 0.620 |
Why?
|
| Tobacco | 2 | 2014 | 5 | 0.620 |
Why?
|
| Kidney Glomerulus | 2 | 2009 | 22 | 0.620 |
Why?
|
| Probiotics | 1 | 2015 | 8 | 0.600 |
Why?
|
| Microbiota | 1 | 2015 | 9 | 0.600 |
Why?
|
| Oxygen | 4 | 2017 | 24 | 0.590 |
Why?
|
| Smoking | 2 | 2014 | 68 | 0.590 |
Why?
|
| Cell Differentiation | 3 | 2013 | 55 | 0.580 |
Why?
|
| Genome, Human | 1 | 2015 | 73 | 0.570 |
Why?
|
| Gene Expression | 7 | 2012 | 75 | 0.570 |
Why?
|
| Hyperinsulinism | 2 | 2013 | 2 | 0.550 |
Why?
|
| Docosahexaenoic Acids | 2 | 2013 | 3 | 0.550 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 2 | 2014 | 2 | 0.540 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 11 | 0.540 |
Why?
|
| Social Environment | 1 | 2014 | 10 | 0.530 |
Why?
|
| Placenta | 4 | 2017 | 14 | 0.530 |
Why?
|
| Cognition | 1 | 2014 | 28 | 0.520 |
Why?
|
| Epigenomics | 1 | 2014 | 25 | 0.520 |
Why?
|
| Jejunum | 2 | 2004 | 7 | 0.510 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2011 | 2 | 0.510 |
Why?
|
| RNA, Long Noncoding | 1 | 2013 | 11 | 0.510 |
Why?
|
| Chromatin Immunoprecipitation | 6 | 2012 | 11 | 0.510 |
Why?
|
| Poverty Areas | 1 | 2013 | 6 | 0.510 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2013 | 8 | 0.510 |
Why?
|
| Estradiol | 1 | 2013 | 5 | 0.500 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 6 | 0.500 |
Why?
|
| Developing Countries | 1 | 2013 | 14 | 0.500 |
Why?
|
| General Surgery | 1 | 2013 | 21 | 0.500 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 20 | 0.500 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2010 | 2 | 0.490 |
Why?
|
| Body Weight | 7 | 2018 | 57 | 0.490 |
Why?
|
| Base Sequence | 8 | 2010 | 114 | 0.490 |
Why?
|
| Dietary Fats | 3 | 2012 | 10 | 0.480 |
Why?
|
| Blood Glucose | 7 | 2015 | 55 | 0.480 |
Why?
|
| Environmental Exposure | 1 | 2012 | 27 | 0.470 |
Why?
|
| Precision Medicine | 1 | 2012 | 32 | 0.470 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 140 | 0.460 |
Why?
|
| Receptor, ErbB-2 | 1 | 2012 | 5 | 0.460 |
Why?
|
| Phosphorylation | 6 | 2017 | 48 | 0.460 |
Why?
|
| Somatomedins | 2 | 2021 | 3 | 0.460 |
Why?
|
| Exons | 6 | 2015 | 40 | 0.460 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2011 | 1 | 0.450 |
Why?
|
| Thymus Gland | 1 | 2011 | 4 | 0.450 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 37 | 0.440 |
Why?
|
| Subcutaneous Fat | 2 | 2013 | 3 | 0.440 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2018 | 67 | 0.430 |
Why?
|
| Elastin | 1 | 2011 | 1 | 0.430 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2019 | 9 | 0.420 |
Why?
|
| Up-Regulation | 4 | 2016 | 29 | 0.420 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 11 | 0.420 |
Why?
|
| Aromatase | 1 | 2010 | 1 | 0.420 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 62 | 0.410 |
Why?
|
| Sex Factors | 6 | 2015 | 77 | 0.410 |
Why?
|
| Serine | 2 | 2007 | 6 | 0.400 |
Why?
|
| Myocardium | 2 | 2018 | 9 | 0.400 |
Why?
|
| Stress, Psychological | 3 | 2018 | 35 | 0.400 |
Why?
|
| Pulmonary Artery | 2 | 2021 | 12 | 0.400 |
Why?
|
| Mitochondria, Muscle | 2 | 2001 | 2 | 0.400 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 13 | 0.400 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 5 | 0.390 |
Why?
|
| Signal Transduction | 3 | 2013 | 151 | 0.390 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 85 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2006 | 14 | 0.380 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2009 | 6 | 0.370 |
Why?
|
| Metabolic Diseases | 1 | 2009 | 13 | 0.370 |
Why?
|
| Infant, Newborn | 7 | 2014 | 887 | 0.370 |
Why?
|
| Research Support as Topic | 2 | 2008 | 6 | 0.370 |
Why?
|
| Adipogenesis | 1 | 2008 | 1 | 0.370 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2014 | 34 | 0.360 |
Why?
|
| Fatty Acids | 2 | 2014 | 4 | 0.350 |
Why?
|
| Mentors | 1 | 2008 | 1 | 0.350 |
Why?
|
| Faculty, Medical | 1 | 2008 | 3 | 0.350 |
Why?
|
| Analysis of Variance | 4 | 2016 | 28 | 0.350 |
Why?
|
| DNA | 2 | 2005 | 72 | 0.350 |
Why?
|
| Age Factors | 3 | 2016 | 220 | 0.340 |
Why?
|
| Infant, Premature | 3 | 2014 | 127 | 0.340 |
Why?
|
| Ileum | 2 | 2004 | 22 | 0.340 |
Why?
|
| High-Frequency Ventilation | 3 | 2013 | 7 | 0.330 |
Why?
|
| Polymerase Chain Reaction | 7 | 2014 | 99 | 0.330 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 7 | 0.330 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 14 | 0.320 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 2 | 0.320 |
Why?
|
| Nucleosomes | 3 | 2015 | 3 | 0.320 |
Why?
|
| Phosphoproteins | 1 | 2006 | 17 | 0.310 |
Why?
|
| Time Factors | 3 | 2014 | 273 | 0.310 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 102 | 0.310 |
Why?
|
| bcl-2-Associated X Protein | 5 | 2010 | 6 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2010 | 10 | 0.310 |
Why?
|
| Inflammation | 2 | 2017 | 48 | 0.300 |
Why?
|
| Adipose Tissue | 3 | 2015 | 31 | 0.300 |
Why?
|
| RNA | 3 | 2012 | 20 | 0.290 |
Why?
|
| Pediatrics | 1 | 2008 | 175 | 0.290 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2015 | 5 | 0.290 |
Why?
|
| Neurons | 2 | 2005 | 37 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 3 | 2013 | 56 | 0.290 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 3 | 0.280 |
Why?
|
| CpG Islands | 4 | 2014 | 48 | 0.280 |
Why?
|
| Biomarkers | 3 | 2014 | 118 | 0.270 |
Why?
|
| Carbon | 1 | 2004 | 1 | 0.270 |
Why?
|
| Flow Cytometry | 2 | 2016 | 30 | 0.270 |
Why?
|
| Macaca | 4 | 2012 | 6 | 0.270 |
Why?
|
| Adiponectin | 3 | 2013 | 6 | 0.260 |
Why?
|
| Adiposity | 2 | 2014 | 10 | 0.260 |
Why?
|
| Cells, Cultured | 3 | 2021 | 113 | 0.250 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 3 | 0.250 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 8 | 0.250 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2020 | 9 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 24 | 0.240 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 11 | 0.240 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2001 | 1 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 144 | 0.230 |
Why?
|
| Enzymes | 1 | 2001 | 5 | 0.220 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2021 | 1 | 0.220 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2021 | 1 | 0.220 |
Why?
|
| Vascular Remodeling | 1 | 2021 | 2 | 0.220 |
Why?
|
| Muscle Proteins | 1 | 2001 | 7 | 0.220 |
Why?
|
| Uterine Artery | 2 | 2012 | 2 | 0.220 |
Why?
|
| Adult | 4 | 2014 | 1107 | 0.220 |
Why?
|
| Sheep | 6 | 2021 | 7 | 0.220 |
Why?
|
| Hypoxia, Brain | 1 | 2001 | 2 | 0.220 |
Why?
|
| Protein Kinases | 3 | 2007 | 8 | 0.220 |
Why?
|
| Cell Proliferation | 1 | 2021 | 70 | 0.220 |
Why?
|
| Heart Ventricles | 1 | 2021 | 32 | 0.210 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 32 | 0.210 |
Why?
|
| Acetylation | 4 | 2015 | 8 | 0.210 |
Why?
|
| Mitochondria | 1 | 2000 | 13 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 87 | 0.200 |
Why?
|
| Organogenesis | 1 | 2019 | 2 | 0.190 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2013 | 87 | 0.190 |
Why?
|
| Lactation | 2 | 2016 | 4 | 0.190 |
Why?
|
| Pregnancy, Animal | 2 | 2012 | 2 | 0.190 |
Why?
|
| Disease Susceptibility | 2 | 2012 | 9 | 0.190 |
Why?
|
| Fibrosis | 1 | 2018 | 5 | 0.190 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2018 | 1 | 0.180 |
Why?
|
| Pituitary-Adrenal System | 1 | 2018 | 1 | 0.180 |
Why?
|
| Behavior, Animal | 1 | 2018 | 2 | 0.180 |
Why?
|
| Down-Regulation | 2 | 2010 | 19 | 0.180 |
Why?
|
| Protein Isoforms | 1 | 2018 | 18 | 0.180 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2018 | 3 | 0.180 |
Why?
|
| Endothelial Cells | 1 | 2018 | 15 | 0.180 |
Why?
|
| Gestational Age | 4 | 2008 | 86 | 0.180 |
Why?
|
| Feedback, Physiological | 1 | 2017 | 1 | 0.170 |
Why?
|
| Absorptiometry, Photon | 3 | 2014 | 20 | 0.170 |
Why?
|
| Immunoblotting | 2 | 2010 | 15 | 0.170 |
Why?
|
| Dietary Supplements | 2 | 2014 | 17 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 18 | 0.170 |
Why?
|
| Carnitine O-Palmitoyltransferase | 3 | 2004 | 3 | 0.170 |
Why?
|
| Eating | 2 | 2014 | 31 | 0.170 |
Why?
|
| Birth Weight | 4 | 2017 | 32 | 0.170 |
Why?
|
| Protective Agents | 1 | 2017 | 3 | 0.160 |
Why?
|
| Premature Birth | 1 | 2017 | 5 | 0.160 |
Why?
|
| Glucose Transporter Type 1 | 3 | 2002 | 3 | 0.160 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2016 | 1 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2016 | 6 | 0.160 |
Why?
|
| Nestin | 1 | 2016 | 6 | 0.160 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2016 | 2 | 0.160 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 12 | 0.160 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 12 | 0.160 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2016 | 1 | 0.160 |
Why?
|
| Histone Code | 2 | 2018 | 8 | 0.160 |
Why?
|
| Transferases | 1 | 1996 | 2 | 0.150 |
Why?
|
| Oxidoreductases | 1 | 1996 | 10 | 0.150 |
Why?
|
| Isothiocyanates | 1 | 2015 | 1 | 0.150 |
Why?
|
| Polyphenols | 1 | 2015 | 1 | 0.150 |
Why?
|
| Disease Resistance | 1 | 2015 | 1 | 0.150 |
Why?
|
| Choline | 1 | 2015 | 2 | 0.150 |
Why?
|
| Fatty Acids, Volatile | 1 | 2015 | 2 | 0.150 |
Why?
|
| Folic Acid | 1 | 2015 | 13 | 0.150 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2015 | 1 | 0.150 |
Why?
|
| Resistance Training | 1 | 2015 | 3 | 0.150 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 120 | 0.150 |
Why?
|
| Nicotine | 1 | 2015 | 11 | 0.150 |
Why?
|
| DNA Helicases | 1 | 2015 | 4 | 0.150 |
Why?
|
| Triglycerides | 3 | 2015 | 21 | 0.140 |
Why?
|
| Caspase 3 | 3 | 2008 | 8 | 0.140 |
Why?
|
| Bone Development | 2 | 2012 | 23 | 0.140 |
Why?
|
| Body Composition | 2 | 2014 | 28 | 0.140 |
Why?
|
| Leptin | 2 | 2013 | 7 | 0.140 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2014 | 4 | 0.140 |
Why?
|
| Food Supply | 1 | 2014 | 11 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2014 | 19 | 0.140 |
Why?
|
| Smoke | 1 | 2014 | 1 | 0.130 |
Why?
|
| Adipokines | 1 | 2014 | 3 | 0.130 |
Why?
|
| Cotinine | 1 | 2014 | 5 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2004 | 4 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 8 | 0.130 |
Why?
|
| Weight Gain | 1 | 2014 | 23 | 0.130 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 1 | 0.130 |
Why?
|
| Epoetin Alfa | 1 | 2014 | 3 | 0.130 |
Why?
|
| Hematocrit | 1 | 2014 | 6 | 0.130 |
Why?
|
| Chemically-Induced Disorders | 1 | 2014 | 1 | 0.130 |
Why?
|
| Nose | 1 | 2013 | 7 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 67 | 0.130 |
Why?
|
| Respiration | 1 | 2013 | 8 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 2014 | 34 | 0.130 |
Why?
|
| Starvation | 1 | 2013 | 1 | 0.130 |
Why?
|
| Fetal Nutrition Disorders | 1 | 2013 | 1 | 0.130 |
Why?
|
| Infant Mortality | 1 | 2013 | 6 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 10 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 97 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 10 | 0.130 |
Why?
|
| Rural Health Services | 1 | 2013 | 3 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2013 | 8 | 0.130 |
Why?
|
| Infant, Low Birth Weight | 1 | 2013 | 13 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2013 | 13 | 0.130 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 17 | 0.130 |
Why?
|
| Molecular Biology | 1 | 2013 | 3 | 0.130 |
Why?
|
| Morphogenesis | 1 | 2013 | 11 | 0.130 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2013 | 3 | 0.120 |
Why?
|
| Treatment Outcome | 1 | 2015 | 624 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 13 | 0.120 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2012 | 2 | 0.120 |
Why?
|
| Thyroid Gland | 1 | 2012 | 6 | 0.120 |
Why?
|
| Sirtuin 1 | 1 | 2012 | 2 | 0.120 |
Why?
|
| Osteogenesis | 1 | 2012 | 10 | 0.120 |
Why?
|
| Arsenic | 1 | 2012 | 5 | 0.120 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 1 | 0.120 |
Why?
|
| Malnutrition | 1 | 2012 | 11 | 0.120 |
Why?
|
| Neuregulin-1 | 1 | 2012 | 1 | 0.120 |
Why?
|
| Ligation | 1 | 2012 | 5 | 0.120 |
Why?
|
| Oligodendroglia | 1 | 2012 | 2 | 0.120 |
Why?
|
| Bone Density | 1 | 2012 | 45 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 5 | 0.120 |
Why?
|
| Astrocytes | 1 | 2012 | 5 | 0.120 |
Why?
|
| Models, Animal | 2 | 2015 | 7 | 0.120 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2011 | 1 | 0.110 |
Why?
|
| Bone Resorption | 1 | 2011 | 3 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 7 | 0.110 |
Why?
|
| CD4-CD8 Ratio | 1 | 2011 | 1 | 0.110 |
Why?
|
| Insulin | 4 | 2015 | 50 | 0.110 |
Why?
|
| Cell Count | 1 | 2011 | 21 | 0.110 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 68 | 0.110 |
Why?
|
| Microvascular Angina | 2 | 2001 | 2 | 0.110 |
Why?
|
| Lung Compliance | 1 | 2011 | 1 | 0.110 |
Why?
|
| Elastic Tissue | 1 | 2011 | 2 | 0.110 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2011 | 8 | 0.110 |
Why?
|
| Cell Division | 2 | 2008 | 20 | 0.110 |
Why?
|
| Glucose Transporter Type 2 | 2 | 2002 | 2 | 0.110 |
Why?
|
| Maze Learning | 1 | 2010 | 1 | 0.110 |
Why?
|
| Histone Deacetylases | 2 | 2012 | 4 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2010 | 47 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2010 | 16 | 0.100 |
Why?
|
| Glucose | 2 | 2001 | 20 | 0.100 |
Why?
|
| Lysine | 2 | 2012 | 6 | 0.100 |
Why?
|
| Oxidation-Reduction | 2 | 2001 | 27 | 0.100 |
Why?
|
| Animals, Domestic | 1 | 2009 | 2 | 0.100 |
Why?
|
| Metabolome | 1 | 2009 | 5 | 0.100 |
Why?
|
| Infant | 1 | 2014 | 1399 | 0.100 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2009 | 3 | 0.090 |
Why?
|
| Testosterone | 1 | 2009 | 14 | 0.090 |
Why?
|
| Aging | 2 | 2007 | 39 | 0.090 |
Why?
|
| Disease Progression | 1 | 2009 | 93 | 0.090 |
Why?
|
| Creatinine | 1 | 2009 | 51 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2009 | 111 | 0.090 |
Why?
|
| Mesoderm | 1 | 2008 | 2 | 0.090 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2008 | 4 | 0.090 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2008 | 4 | 0.090 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 5 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 10 | 0.090 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2008 | 3 | 0.090 |
Why?
|
| Fellowships and Scholarships | 1 | 2008 | 17 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2021 | 101 | 0.090 |
Why?
|
| Hyperplasia | 1 | 2007 | 5 | 0.080 |
Why?
|
| Phospholipids | 1 | 2007 | 6 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2007 | 3 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2007 | 14 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 5 | 0.080 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2007 | 1 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2007 | 18 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2006 | 1 | 0.080 |
Why?
|
| Young Adult | 1 | 2009 | 594 | 0.080 |
Why?
|
| Pharmacology | 1 | 2006 | 1 | 0.080 |
Why?
|
| Neonatology | 1 | 2006 | 10 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2012 | 132 | 0.080 |
Why?
|
| Zinc | 1 | 2005 | 4 | 0.080 |
Why?
|
| Molecular Structure | 1 | 2005 | 5 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2021 | 130 | 0.070 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2006 | 33 | 0.070 |
Why?
|
| Cyclin A | 1 | 2005 | 3 | 0.070 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 48 | 0.070 |
Why?
|
| United States | 1 | 2008 | 640 | 0.070 |
Why?
|
| Binding Sites | 2 | 2015 | 50 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2004 | 18 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 4 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2004 | 15 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 1 | 2004 | 12 | 0.070 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2004 | 1 | 0.070 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2004 | 1 | 0.070 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2004 | 2 | 0.070 |
Why?
|
| Methionine | 1 | 2004 | 5 | 0.070 |
Why?
|
| Enzyme Induction | 1 | 2004 | 5 | 0.070 |
Why?
|
| Homeostasis | 1 | 2004 | 16 | 0.070 |
Why?
|
| Phenotype | 1 | 2004 | 222 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 186 | 0.070 |
Why?
|
| DNA Modification Methylases | 1 | 2003 | 1 | 0.060 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2004 | 67 | 0.060 |
Why?
|
| Animal Feed | 1 | 2002 | 1 | 0.060 |
Why?
|
| Animals, Suckling | 1 | 2002 | 1 | 0.060 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2002 | 1 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 9 | 0.060 |
Why?
|
| Milk | 1 | 2002 | 7 | 0.060 |
Why?
|
| Lactase | 1 | 2002 | 3 | 0.060 |
Why?
|
| Gluconeogenesis | 1 | 2002 | 2 | 0.060 |
Why?
|
| Physical Stimulation | 2 | 2013 | 3 | 0.060 |
Why?
|
| Diet | 1 | 2002 | 52 | 0.060 |
Why?
|
| Ketone Oxidoreductases | 1 | 2001 | 1 | 0.060 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2001 | 1 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 3 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2021 | 1 | 0.060 |
Why?
|
| Vasoconstrictor Agents | 1 | 2021 | 3 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2021 | 10 | 0.060 |
Why?
|
| Glycogen | 1 | 2001 | 1 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2021 | 3 | 0.060 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2001 | 2 | 0.060 |
Why?
|
| Hexokinase | 1 | 2001 | 2 | 0.060 |
Why?
|
| Organ Size | 1 | 2001 | 18 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2001 | 33 | 0.050 |
Why?
|
| Malondialdehyde | 1 | 2001 | 1 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2001 | 2 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2001 | 6 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2001 | 16 | 0.050 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2001 | 1 | 0.050 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2001 | 1 | 0.050 |
Why?
|
| Malonyl Coenzyme A | 1 | 2001 | 1 | 0.050 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2001 | 1 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 7 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2000 | 3 | 0.050 |
Why?
|
| Random Allocation | 1 | 2020 | 11 | 0.050 |
Why?
|
| Biomedical Research | 2 | 2013 | 26 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 1 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 2 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2019 | 10 | 0.050 |
Why?
|
| Transcriptome | 1 | 2019 | 35 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 1999 | 19 | 0.050 |
Why?
|
| Heart | 1 | 2018 | 14 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 74 | 0.050 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 1 | 1998 | 1 | 0.040 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1998 | 1 | 0.040 |
Why?
|
| Proton-Translocating ATPases | 1 | 1998 | 1 | 0.040 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1998 | 1 | 0.040 |
Why?
|
| Electron Transport Complex I | 1 | 1998 | 3 | 0.040 |
Why?
|
| NAD | 1 | 1998 | 3 | 0.040 |
Why?
|
| Muscle Development | 1 | 1998 | 3 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2017 | 1 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2017 | 18 | 0.040 |
Why?
|
| Retinal Neovascularization | 1 | 2017 | 1 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 10 | 0.040 |
Why?
|
| Rhodopsin | 1 | 1996 | 1 | 0.040 |
Why?
|
| Cattle | 1 | 1996 | 26 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 1996 | 25 | 0.040 |
Why?
|
| Reflex | 1 | 2015 | 2 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2015 | 3 | 0.040 |
Why?
|
| Body Size | 1 | 2015 | 8 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2015 | 22 | 0.040 |
Why?
|
| Methylation | 1 | 2015 | 17 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2015 | 13 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 2015 | 2 | 0.040 |
Why?
|
| Transcription Initiation Site | 1 | 2015 | 2 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 5 | 0.040 |
Why?
|
| Thromboxane A2 | 1 | 2015 | 3 | 0.040 |
Why?
|
| Motor Activity | 1 | 2015 | 34 | 0.040 |
Why?
|
| Response Elements | 1 | 2014 | 3 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 3 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2014 | 8 | 0.030 |
Why?
|
| Lipids | 1 | 2014 | 7 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 12 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 8 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 30 | 0.030 |
Why?
|
| Risk Factors | 1 | 2015 | 393 | 0.030 |
Why?
|
| Receptors, Adiponectin | 1 | 2013 | 1 | 0.030 |
Why?
|
| Hyperoxia | 1 | 2013 | 13 | 0.030 |
Why?
|
| Iodide Peroxidase | 1 | 2012 | 1 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2012 | 2 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2012 | 4 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2012 | 1 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2012 | 5 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 2012 | 8 | 0.030 |
Why?
|
| COS Cells | 1 | 2012 | 21 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2012 | 20 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 15 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2012 | 8 | 0.030 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2011 | 3 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 144 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 42 | 0.030 |
Why?
|
| Mutation | 1 | 2012 | 202 | 0.030 |
Why?
|
| Infant Food | 1 | 2011 | 7 | 0.030 |
Why?
|
| Weaning | 1 | 2010 | 1 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2015 | 1459 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2009 | 3 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 72 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2009 | 18 | 0.020 |
Why?
|
| Adolescent | 1 | 2015 | 1976 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 3 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2008 | 2 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 5 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 44 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2008 | 11 | 0.020 |
Why?
|
| Child | 1 | 2015 | 2874 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 308 | 0.020 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2006 | 17 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2008 | 1196 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2002 | 2 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1999 | 5 | 0.010 |
Why?
|